Allergan Inc. said the U.S. Department of Justice is probing whether the company promoted the wrinkle smoother Botox as an unapproved headache treatment. The U.S. attorney’s office subpoenaed documents from Allergan related to Botox marketing and education, the company said. Botox isn’t approved by the U.S. Food and Drug Administration as a headache treatment.
Questions or Comments? 
